Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman
View: Text | PDF
Research Article Angiogenesis Reproductive biology

Hyaluronan control of the primary vascular barrier during early mouse pregnancy is mediated by uterine NK cells

  • Text
  • PDF
Abstract

Successful implantation is associated with a unique spatial pattern of vascular remodeling, characterized by profound peripheral neovascularization surrounding a periembryo avascular niche. We hypothesized that hyaluronan controls the formation of this distinctive vascular pattern encompassing the embryo. This hypothesis was evaluated by genetic modification of hyaluronan metabolism, specifically targeted to embryonic trophoblast cells. The outcome of altered hyaluronan deposition on uterine vascular remodeling and postimplantation development were analyzed by MRI, detailed histological examinations, and RNA sequencing of uterine NK cells. Our experiments revealed that disruption of hyaluronan synthesis, as well as its increased cleavage at the embryonic niche, impaired implantation by induction of decidual vascular permeability, defective vascular sinus folds formation, breach of the maternal-embryo barrier, elevated MMP-9 expression, and interrupted uterine NK cell recruitment and function. Conversely, enhanced deposition of hyaluronan resulted in the expansion of the maternal-embryo barrier and increased diffusion distance, leading to compromised implantation. The deposition of hyaluronan at the embryonic niche is regulated by progesterone-progesterone receptor signaling. These results demonstrate a pivotal role for hyaluronan in successful pregnancy by fine-tuning the periembryo avascular niche and maternal vascular morphogenesis.

Authors

Ron Hadas, Eran Gershon, Aviad Cohen, Ofir Atrakchi, Shlomi Lazar, Ofra Golani, Bareket Dassa, Michal Elbaz, Gadi Cohen, Raya Eilam, Nava Dekel, Michal Neeman

×

Figure 9

Trophectoderm overexpression of HAS-2 resulted in early embryonic lethality and attenuated decidual angiogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Trophectoderm overexpression of HAS-2 resulted in early embryonic lethal...
(A) H&E staining of implantation sites revealed embryo resorption upon HAS-2 OEx (n = 4 dams). (B) Remnants of embryo overexpressing HAS-2 by trophoblast cells (CK-7) as opposed to decidual cells expressing HAS-2 in the embryonic niche in the control (n = 3 dams). (C) Profound embryonic cell death indicated by TUNEL staining was detected upon HAS-2 OEx, (n = 3 dams). (D) Similar pattern of MAC-2+ macrophages, confined to the mesometrial pole, away from the embryonic niche, observed in both groups (n = 3 dams). (E) Quantification MAC-2 staining by fluorescent microscopy (1.066-fold change ± 0.18 [control]; 0.41 [overexpression]; n = 5 dams, 7 implantation sites, P = 0.879). (F) Number of embryo implantation site per dam was assessed, at E6.5 by gross morphology inspection, as well as by examination of histological sections (3 ± 0.63 [control]; 2.88 ± 0.61 [overexpression], P = 0.88) (n = 6 dams in control; 8 dams in HAS-2 OEx). (G) Representative image of DBA+ NK cells in E6.5 decidua (n = 3 dams). (H) Representative image of MMP-9 in E6.5 decidua (n = 3 dams). (I) Impaired development of CD34+ newly formed blood vessels was observed in pregnant mice carrying HAS-2 OEx embryos, reflected by confinement of vessels away from the embryonic niche (n = 3 dams). (J) T1 weighted GE-MRI of embryo implantation sites, acquired from pregnant mice at E6.5 30 minutes after administration of biotin-BSA-GdDTPA. Little accumulation of biotin-BSA-GdDTPA was observed in the in dams carrying HAS-2 OEx embryos in comparison with control (white arrows indicate implantation sites; n = 6 dams). (K) Visualization of hyperpermeable blood vessels in the embryonic niche was achieved by staining of biotin-BSA-GdDTPA, 40 minutes after i.v. injection. Hyperpermeable vessels were not detected at HAS-2 OEx decidua in contrast to those detected in the control group (n = 3 dams). (L–N) These observations were consistent with DCE-MRI of biotin-BSA-GdDTPA (L), fBV (M) (0.041 ± 0.005; 0.023 ± 0.002; P = 0.004) and PS (N) (0.0017 ± 0.0003; 0.0009 ± 0.00031; P = 0.2) (control: 5 dams 9 implantation sites; HAS-2 OEx: 6 dams 19 implantation sites). The statistical analysis applied was Student’s t test (E, F, M, and N).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts